MHC II molecules in inflammatory diseases: interplay of qualities and quantities.

It is generally accepted that MHC II molecules confer susceptibility to inflammatory diseases because of the different abilities they possess for binding and presenting peptides to T cells. A new study suggests that the level of MHC II gene expression is also a risk factor for such diseases. It show...

Full description

Bibliographic Details
Main Authors: Friese, M, Jones, E, Fugger, L
Format: Journal article
Language:English
Published: 2005
_version_ 1797082442918526976
author Friese, M
Jones, E
Fugger, L
author_facet Friese, M
Jones, E
Fugger, L
author_sort Friese, M
collection OXFORD
description It is generally accepted that MHC II molecules confer susceptibility to inflammatory diseases because of the different abilities they possess for binding and presenting peptides to T cells. A new study suggests that the level of MHC II gene expression is also a risk factor for such diseases. It shows that a polymorphism in the promoter of the MHC II transactivator (MHC2TA) gene (which encodes CIITA), leads to reduced MHC2TA expression, and hence reduced production of MHC II molecules. This predisposes to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
first_indexed 2024-03-07T01:28:10Z
format Journal article
id oxford-uuid:92ae3241-abf2-41f5-a2d5-5da24a34eb6a
institution University of Oxford
language English
last_indexed 2024-03-07T01:28:10Z
publishDate 2005
record_format dspace
spelling oxford-uuid:92ae3241-abf2-41f5-a2d5-5da24a34eb6a2022-03-26T23:27:15ZMHC II molecules in inflammatory diseases: interplay of qualities and quantities.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:92ae3241-abf2-41f5-a2d5-5da24a34eb6aEnglishSymplectic Elements at Oxford2005Friese, MJones, EFugger, LIt is generally accepted that MHC II molecules confer susceptibility to inflammatory diseases because of the different abilities they possess for binding and presenting peptides to T cells. A new study suggests that the level of MHC II gene expression is also a risk factor for such diseases. It shows that a polymorphism in the promoter of the MHC II transactivator (MHC2TA) gene (which encodes CIITA), leads to reduced MHC2TA expression, and hence reduced production of MHC II molecules. This predisposes to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
spellingShingle Friese, M
Jones, E
Fugger, L
MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
title MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
title_full MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
title_fullStr MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
title_full_unstemmed MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
title_short MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
title_sort mhc ii molecules in inflammatory diseases interplay of qualities and quantities
work_keys_str_mv AT friesem mhciimoleculesininflammatorydiseasesinterplayofqualitiesandquantities
AT jonese mhciimoleculesininflammatorydiseasesinterplayofqualitiesandquantities
AT fuggerl mhciimoleculesininflammatorydiseasesinterplayofqualitiesandquantities